PROTHENA CORPORATION PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.57 USD | -2.05% |
|
-11.64% | -43.40% |
| Mar. 04 | Prothena Names David Ford as Chief People Officer | MT |
| Mar. 04 | Prothena Appoints David Ford to Newly Created Chief People Officer | CI |
Chart calendar Prothena Corporation plc
a50571caa0a94.LC1mQEhG2Dle_rbuRj1OVcrhYbrkcIuwJI-oSI3pNNw.WkwPKi0Sjk9zzMKnInIoArPRGdaxBbvWQeaRONmGTaRAVTA1BgSubASE_w~7697342fde9c18fbe667393e6fbc7e17
Upcoming events on Prothena Corporation plc
Past events on Prothena Corporation plc
| 2024-03-12 | Jefferies Biotech on the Bay Summit |
| 2024-03-12 10:00 am | Leerink Partners Global Biopharma Conference - Fireside Chat |
| 2024-02-15 04:30 pm | Q4 2023 Earnings Call |
| 2024-02-15 04:05 pm | Q4 2023 Earnings Release |
| 2023-11-02 04:05 pm | Q3 2023 Earnings Release |
| 2023-09-11 02:15 pm | Morgan Stanley Global Healthcare Conference |
| 2023-09-06 | Citi BioPharma Conference |
| 2023-08-03 04:05 pm | Q2 2023 Earnings Release |
| 2023-07-15 | Alzheimer Association International Conference - Poster No #74811 |
| 2023-07-15 | Alzheimer Association International Conference - Poster No #82687 |
| 2023-07-15 | Alzheimer Association International Conference - Poster No #74181 |
| 2023-06-08 01:00 pm | Jefferies Global Healthcare Conference |
| 2023-05-16 11:00 am | Annual General Meeting |
| 2023-05-09 12:20 pm | Bank of America Healthcare Conference |
| 2023-05-04 04:05 pm | Q1 2023 Earnings Release |
| 2023-03-31 12:20 pm | Alzheimer & Parkinson Disease International Conference - Panel |
| 2023-03-31 09:20 am | Alzheimer & Parkinson Disease International Conference - Abstract number: 2480 |
| 2023-03-30 03:40 am | Alzheimer & Parkinson Disease International Conference |
| 2023-03-29 11:55 am | Alzheimer and Parkinson Diseases International Conference - Panel |
| 2023-03-29 02:00 am | Alzheimer & Parkinson Disease International Conference - Poster Number : 338 / #2095 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,81 0,72 12.94% | 0,85 0,64 32.86% | 201 205 -2.39% | 53,9 43,0 25.33% | 91,4 89,4 2.17% | 13,4 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | -111 -116 3.94% | 73,1 75,2 -2.82% | 0,00 -146 - | -190 -274 30.63% | -411 |
|
EBIT Million USD | Released Forecast Spread | -85,7 -86,0 0.38% | -113 -115 1.57% | 72,0 79,5 -9.44% | -132 -146 10.06% | -191 -194 1.41% | -299 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -77,3 -78,4 1.4% | -111 -111 -0.62% | 71,9 87,8 -18.12% | -126 -140 10.51% | -160 -168 4.73% | -283 |
|
Net income Million USD | Released Forecast Spread | -77,7 -78,8 1.45% | -111 -111 0.3% | 67,0 68,4 -2.03% | -117 -140 16.5% | -147 -153 4.15% | -262 |
|
EPS USD | Released Forecast Spread | -1,95 -1,98 1.39% | -2,78 -2,79 0.26% | 1,38 1,44 -3.88% | -2,47 -2,93 15.67% | -2,76 -2,87 3.99% | -4,81 |
| Announcement Date | 12/02/20 | 11/02/21 | 17/02/22 | 23/02/23 | 15/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,17 11,8 -90.08% | 1,15 10,1 -88.53% | 1,31 17,2 -92.36% | 1,52 25,2 -93.98% | 49,9 29,1 71.33% | 2,17 7,53 -71.18% | 4,02 4,52 -11.13% | 84,9 41,7 103.56% | 0,32 2,72 -88.39% | 2,17 | 2,17 | 2,17 | 8,42 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -33,1 -22,3 -48.46% | -37,9 -29,8 -27.31% | -43,2 -23,7 -82.66% | -50,3 -23,4 -114.78% | -0,07 -27,3 99.74% | -56,3 -40,5 -38.94% | -66,5 -52,9 -25.67% | 10,3 -27,3 137.69% | -78,5 -76,8 -2.19% | -73,2 | -73,7 | -74,9 | -76,3 | -75,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -33,1 -13,8 -139.43% | -38,0 -25,5 -48.78% | -42,6 -31,4 -35.52% | -48,4 -39,7 -21.9% | 3,35 -22,6 114.8% | -49,8 -46,3 -7.62% | -58,9 -60,0 1.84% | 18,8 -35,6 152.87% | -70,6 -74,6 5.3% | -69,4 | -69,8 | -71,7 | -74,7 | -83,1 |
|
Net income Million USD | Released Forecast Spread | -33,2 -22,2 -49.58% | -36,3 -29,7 -21.98% | -41,2 -23,6 -74.59% | -45,8 -23,3 -96.18% | 6,35 -26,4 124.05% | -46,9 -40,0 -17.3% | -54,6 -50,0 -9.27% | 21,9 -18,6 217.64% | -67,5 -67,0 -0.65% | -65,3 | -66,0 | -67,7 | -69,7 | -75,3 |
|
EPS USD | Released Forecast Spread | -0,71 -0,48 -49.25% | -0,78 -0,66 -18.18% | -0,88 -0,57 -54% | -0,97 -0,56 -72.44% | 0,12 -0,49 124.71% | -0,89 -0,81 -10.46% | -1,03 -0,97 -5.7% | 0,38 -0,32 217.93% | -1,26 -1,23 -2.72% | -1,22 | -1,23 | -1,25 | -1,30 | -1,35 |
| Announcement Date | 17/02/22 | 05/05/22 | 08/08/22 | 03/11/22 | 23/02/23 | 04/05/23 | 03/08/23 | 02/11/23 | 15/02/24 | - | - | - | - | - |
More events
Past sector events for Prothena Corporation plc
| 2024-04-17 | BEIJING KAWIN TECHNOLOGY SHARE-HOLDING CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-04-17 | JIANGSU YAHONG MEDITECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-12 | SINOCELLTECH GROUP LIMITED: Q4 2023 Earnings Release |
| 2024-04-10 07:00 am | NURIX THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-04-08 | MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-02 03:06 am | TAIMED BIOLOGICS INC.: March 2024 Sales and Revenue Release |
| 2024-03-31 | PEPTRON, INC.: Q4 2023 Earnings Release (Projected) |
| 2024-03-31 | BIONEER CORPORATION: Q4 2023 Earnings Release (Projected) |
| 2024-03-29 08:30 am | INNOCARE PHARMA LIMITED: Q4 2023 Earnings Release |
| 2024-03-28 | BIO-THERA SOLUTIONS, LTD.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PRTA Stock
- Calendar Prothena Corporation plc
